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An atomic absorption spectrophotometric analysis on dose and duration dependent aluminum 
concentration in serum, liver and brain digests of three groups of male Wistar albino rats were 
investigated after seven and fourteen days of daily 0.38mg/kg, 3.8mg/kg and 38mg/kg aluminum 
administration respectively. The results showed that the test animals given the highest dose of (3.8mg/kg 
bw) of toxicant increase significantly (p<0.05) in aluminum concentration in serum, liver and brain digest 
after seven days when compared to the control animals. However, the mid and highest dose (38 and 
38mg/kg bw) of toxicant significantly increased (p<0.05) in aluminum concentration in all the digest after 
fourteen days of exposure to aluminium. It is therefore concluded that increase in aluminum 
administration in male Wistar albino rats may predispose the animals to increase in aluminium 
concentration in the serum, liver and brain which is dose and duration dependent.  
 




Human systems have inorganic elements as their 
integral constituents. These inorganic elements may 
either be classified as bulk elements or trace 
elements, which aid in the growth and metabolism. 
Aluminum is neither classified as a bulk element nor 
does trace element yet find its way into the human 
system. However, it is considered to have no 
definite biological role (Devoto and Yokel, 1994). 
The human dietary intake of aluminum 
averages about 30-50mg daily (Ganrot, 1986). This 
daily intake can be increased by aluminum 
containing drugs such as antacids, vaccines, 
aspirin, etc. (Greger, 1992) 
   Aluminum is released into the 
environment both by natural and anthropogenic 
sources. It is ubiquitous, being the third most 
prevalent element and the most abundant metal in 
the earth’s surface mainly in the combined form as 
silicates, oxides and hydroxides (WHO, 1997).             
Aluminum has a variety of applications 
such as in food industry (as a packaging foil and 
drying agents), pharmaceutical industry (as an 
anticholinesterase and antiperspirant) and 
engineering works (in construction of roof sheets, 
vehicle parts etc). Perhaps the numerous 
applications of aluminum is because of its light-
weight, corrosion- free, and relative 
inexpensiveness (Kandiah and Kies, 1994). 
 Aluminum transverses across the cell 
membrane and enters into the blood circulation 
where it binds to the serum proteins, particularly 
transferrin (Moshtaghie and Ani, 1992). It is then 
absorbed by cells through transferrin receptors 
similar to iron absorption (Skillen and Moshtaghie, 
1997). The target tissues for aluminum burden are 
bone, brain, kidney and liver (Ajoy et al., 1990). 
However, aluminum is a known neurotoxin 
that can predispose to certain diseases such as 
Alzheimer’s, dementia, Parkinsonism and 
amyotropic lateral sclerosis (Wurtman, 1985; 
Alferey et al., 1976). It also affects some body 
structures like the skeletal system, brain tissues and 
blood cells (Ajoy et al., 1990, Mestaghanmi et al., 
2002). Aluminum is absorbed by cells through 
transferrin receptors similar to iron absorption 
(Skillen and Moshtaghie, 1997).  
 However, in spite of the known toxicity of 
aluminium until recently, there was little concern 
about dose and duration dependent of aluminium 
ingestion because it was assumed that aluminium 
was not orally bioavailable.  
 The objective of the study is to investigate 
the potentials of dose and duration of aluminium 
administration as a factor in aluminum accumulation 
in tissues of experimental animals. This study 
serves as a yardstick to find out whether aluminium 
accumulates faster in body tissues than the body’s 
detoxification pathways can dispose of, resulting in 
a gradual build up of the metal in tissues. 
 
Materials and Methods 
 
Materials: Twenty-four (24) male Wistar albino rats 
aged between 8-10 weeks with a body weight range 
of 150-205g were purchased from the animal house 
of the Faculty of Vertinary Medicine, University of 
Nigeria, Nsukka. The toxicant administered daily to 
the experimental animals was aluminum as in 
aluminum chloride (AlCl3) at varying doses: 0.38, 
3.8 and 38 mg/kg body weight while the control 
animals received normal saline (0.2ml). All 
chemicals used were of the analytical grade.  
 
Methods: The animals were housed and distributed 
randomly in four separate metabolic rat cages of six 
each differentially marked and acclimatized for five 
days. The four groups were labeled A to D. while 
group A is the control administered  0.2ml normal 
saline used in dissolving the toxicant, groups B, C 
and D were the treatment groups administered 
0.38, 3.8 and 38mg/kg body weight daily of the 
aluminum as in aluminum chloride (AlCl3) 
respectively. The route of administration was oral by 
means of gastric intubation. All animals were fed 
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with commercial feed (grower’s mash) and water ad 
libitum for seven (7) and fourteen (14) days 
respectively. Each experiment was replicated thrice 
and results were pooled.  
 Blood was collected from each group on 
the days 7 and 14 through the median cantus vein 
in the eyes of the rats with the aid of a capillary tube 
and transferred into plastic test tubes. This was 
later centrifuged at 2000 x g in separate test tubes. 
The animals were later sacrificed, and dissected. 
The organs such as the liver and brain were 
removed, washed with normal saline, weighed and 
digested by the method of Taylor and Walker 
(1992). The absorbance of the clear supernatant 
was read at 375nm against the blank using atomic 
absorption spectrophotometer. The aluminum 
concentrations in µg/l of the samples were 
extrapolated from a standard curve. 
 
Statistical analysis: Significant differences were 
assessed by one way analysis of variance (ANOVA) 
while differences between treatment groups were 
calculated using student’s independent t- test. The 
acceptance level of significance was p < 0.05 using 




Figure 1 below shows no significant increase (P 
>0.05) in the aluminium concentration in serum, and 
liver for the test groups administered 0.38mg/kg and 
3.8mg/k g body weight while the test group 
administered 38 mg/kg increased significantly (P  
 
<0.05) relative to the control group after day seven. 
The aluminium concentration in brain digest was 
significantly higher (P <0.05) in the test groups 
administered 3.8mg/kg and 38mg/kg body weight of 
AlCl3   after the seven days compared to the control 
group. 
 After fourteen days of aluminum exposure, 
the aluminum concentration in the brain of all the 
test groups were significantly higher (P<0.05) 
compared to the control group. However, aluminum 
concentration in the serum and liver were 
significantly higher (P< 0.05) in the test groups 
administration 3.8mg/kg and 38mg/kg relative to the 
control group. Results from figures 1 and 2 indicate 
that aluminum concentration in the serum; liver and 
brain digests increased markedly from the 7th day to 




A search for the understanding on dose and 
duration depends of aluminium administration as a 
basis of its toxicity has stimulated very many 
experimental studies. In the present study, an 
attempt was made to delineate the potentials of 
dose and duration dependent of aluminium 
administration as a factor in aluminium 
accumulation in tissues of experimental animal. The 
results showed that aluminum concentration was 
more in the brain digest after days 7 and 14 
respectively when compared to the serum and liver 
digests of other test animals at varying doses. The 
result may support the findings of Julka and Gill 
(1996) on the neurochemical effects of aluminum. 
The author said that aluminum inhibits cholinergic 
functioning as well as synaptic uptake of dopamine, 
norepinephrine and 5-hydroxytryptamine as well as 
inhibits Na-K ATPase and hexokinase activities. 
Hence aluminum decreases spontaneous nervous 
discharge, thereby reducing nervous activity. All 
these neurological effects of aluminum may be 
linked up with the bioavailability of aluminum in the 
brain tissues through aluminum intoxication. 
Aluminum accumulation has been implicated in 
neurological diseases such as Alzheimer’s. 
dementia, Parkinsonism and amyotrophic lateral 
sclerosis (Alferey et al., 1986). Results from figures 
l and 2 indicate that aluminum concentration in the 
serum, liver and brain digests increased markedly 
from the 7th day to 14th day in all the test animals. 
Statistically, aluminum concentrations were 
significantly higher (p<0.05) in the digests of the 
test animals given the three doses of the toxicant 
after fourteen days when compared with that of 
seven days. This elevation dependent on the dose 
and duration of exposure. Sampson et al., (1989) 
found that serum aluminium concentration in renal 
patients maintained on haemodialysis was high and 
correlates with the intake and duration of aluminium 
consumption in chronic renal failure. 
 Fig. 1: Mean Aluminium concentration  in 
























Conclusion: On the basis of these findings, it is 
concluded that aluminium accumulation in tissues of 
experimental animals were dose and duration 
dependent   
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